Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Orion discontinues development of new COMT inhibitor for Parkinson's disease

May 14, 2008

FDA approves Strattera for maintenance of ADHD in children and adolescents

May 13, 2008

Preclinical data on Pfizer's alpha2delta ligand PD-0200390 reported

May 13, 2008

Org-52186 shows potential for treating anxiety and depression

May 13, 2008

Taisho initiates phase I clinical trial of psychiatric drug candidate under partnership with Arena

May 9, 2008

FDA approves Abilify for add-on treatment to lithium or valproate in bipolar I

May 9, 2008

FDA Advisory Committee votes in favor of approval of fospropofol disodium

May 9, 2008

KeyNeurotek's phase I KN38-7271 study meets all endpoints

May 9, 2008

AstraZeneca submits sNDA for Seroquel XR for GAD

May 9, 2008

Memantine reduces hyperactivity in a rat mania model

May 9, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...